Immune Regulation and DynPort Vaccine Company partner to advance COVID-19 drug in clinical trials EP News Bureau Jul 6, 2020 Immune Regulation’s drug candidate IRL201104 has been shown to quickly and markedly reduce excessive infiltration of neutrophils…
